Literature DB >> 28655779

A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT.

Müberra Ahci1, Cristina Toffalori2, Evelien Bouwmans3, Pietro Crivello1, Chiara Brambati2, Cinzia Pultrone2, Karin Stempelmann1, Douglas Bost4, Benedetta Mazzi2, Dietrich W Beelen5, Fabio Ciceri6,7, Wietse Mulder3,4, Katharina Fleischhauer1,8, Luca Vago2,6.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28655779     DOI： 10.1182/blood-2017-05-784306

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  12 in total

1.  Haplo, we have a problem.

Authors:  Christopher S Hourigan
Journal:  Blood       Date:  2017-09-07       Impact factor: 22.113

2.  Clonal evolution and immune evasion in posttransplantation relapses.

Authors:  Luca Vago
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 3.  Epidemiology and biology of relapse after stem cell transplantation.

Authors:  Mary Horowitz; Hans Schreiber; Alex Elder; Olaf Heidenreich; Josef Vormoor; Christina Toffalori; Luca Vago; Nicolaus Kröger
Journal:  Bone Marrow Transplant       Date:  2018-04-18       Impact factor: 5.483

Review 4.  A practical guide to chimerism analysis: Review of the literature and testing practices worldwide.

Authors:  Amanda G Blouin; Fei Ye; Jenifer Williams; Medhat Askar
Journal:  Hum Immunol       Date:  2021-08-14       Impact factor: 2.211

Review 5.  Chimerism analysis for clinicians: a review of the literature and worldwide practices.

Authors:  Amanda G Blouin; Medhat Askar
Journal:  Bone Marrow Transplant       Date:  2022-01-26       Impact factor: 5.174

6.  Blinatumomab for HLA loss relapse after haploidentical hematopoietic stem cell transplantation.

Authors:  Hengwei Wu; Zhen Cai; Jimin Shi; Yi Luo; He Huang; Yanmin Zhao
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

7.  Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia.

Authors:  Laura W Dillon; Sheida Hayati; Gregory W Roloff; Ilker Tunc; Mehdi Pirooznia; Antonina Mitrofanova; Christopher S Hourigan
Journal:  Haematologica       Date:  2018-08-31       Impact factor: 9.941

8.  Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide.

Authors:  Paula Muñiz; Mi Kwon; Diego Carbonell; María Chicano; Rebeca Bailén; Gillen Oarbeascoa; Julia Suárez-González; Cristina Andrés-Zayas; Javier Menárguez; Nieves Dorado; Ignacio Gómez-Centurión; Javier Anguita; José Luis Díez-Martín; Carolina Martínez-Laperche; Ismael Buño
Journal:  Front Immunol       Date:  2021-03-25       Impact factor: 7.561

Review 9.  Novel agents targeting leukemia cells and immune microenvironment for prevention and treatment of relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.

Authors:  Wei Shi; Weiwei Jin; Linghui Xia; Yu Hu
Journal:  Acta Pharm Sin B       Date:  2020-06-30       Impact factor: 11.413

Review 10.  Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation.

Authors:  Pier Edoardo Rovatti; Valentina Gambacorta; Francesca Lorentino; Fabio Ciceri; Luca Vago
Journal:  Front Immunol       Date:  2020-02-25       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.